Neurofilament Light Chain Levels as Diagnostic and Prognostic Biomarkers in Guillain–Barré Syndrome: An Updated Systematic Review and Meta-Analysis
Serum NfL is a promising biomarker for early diagnosis and prognosis in GBS and may support risk stratification at hospital admission.
Authors
- Francesca Vitali (ORCID: https://orcid.org/0000-0002-3177-1575)
- Marco Luigetti (ORCID: https://orcid.org/0000-0001-7539-505X)
- Valeria Guglielmino (ORCID: https://orcid.org/0000-0002-9049-5988)
- Guido Primiano (ORCID: https://orcid.org/0000-0001-7616-7008)
- Maria Ausilia Sciarrone (ORCID: https://orcid.org/0000-0002-1490-0320)
- Giovanni Siconolfi
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
- University of the Sacred Heart (JP)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2025-09-21
- DOI
- https://doi.org/10.1007/s40120-025-00830-x
- Citations
- 3
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.17